Abstract
Induction of apoptosis by chemotherapeutic drugs involves the sphingomyelin-ceramide (SM-CER) pathway. This signaling is critically dependent on reactive oxygen species (ROS) generation and p53/p56 Lyn activation. In this study, we have investigated the influence of protein kinase C (PKC) ζ overexpression on the SM-CER pathway in U937 human leukemia cell line. We show that PKCζ overexpression resulted in delayed apoptosis and significant resistance to both 1-β-d-arabinofuranosylcytosine (ara-C) and daunorubicin (DNR), but there was no significant protection against cell-permeant C6-CER. Moreover, PKCζ overexpression abrogated drug-induced neutral sphingomyelinase stimulation and CER generation by inhibiting ROS production. We further investigated p53/p56 Lyn activation in PKCζ-overexpressing U937 cells treated with ara-C or DNR. We demonstrate that PKCζ inhibited p53/p56 Lyn phosphorylation and stimulation in drug- or H2O2-treated cells, suggesting that p53/p56 Lyn redox regulation is altered in PKCζ-overexpressing cells. Finally, we show that PKCζ-overexpressing U937 cells displayed accelerated H2O2 detoxification. Altogether, our study provides evidence for the role of PKCζ in the negative regulation of drug-induced SM-CER pathway.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|